| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |